
AdaptHealth Corp (AHCO) Stock Forecast & Price Target
AdaptHealth Corp (AHCO) Analyst Ratings
Bulls say
AdaptHealth Corp is expected to realize an annual topline growth of 12-15% through ongoing investments in technology and strategic mergers and acquisitions within its fragmented industry. The recent acquisition of AeroCare strengthens the company's national footprint and enhances its value proposition with payors, while also advancing its connected health strategy. Additionally, the company's scalable platform and low-cost infrastructure are anticipated to foster strong operating leverage and margin expansion as it continues to capitalize on cross-selling opportunities and expand its product offerings.
Bears say
AdaptHealth Corp has reported a decline in key revenue segments, with diabetes revenue dropping by 8.0% year-over-year and sleep revenue falling by 3.0%, indicating challenges in two crucial areas of its business. The company has also revised its 2025 revenue and adjusted EBITDA guidance downwards by $40 million and $5 million, respectively, reflecting concerns about market share and asset sales. Furthermore, the potential for unforeseen acquisition integration difficulties and the failure to achieve operating leverage could negatively impact adjusted EBITDA, contributing to a negative outlook on the stock.
This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.
AdaptHealth Corp (AHCO) Analyst Forecast & Price Prediction
Start investing in AdaptHealth Corp (AHCO)
Order type
Buy in
Order amount
Est. shares
0 shares